A Seamless Phase II/III Design with Sample-Size Re-Estimation

ISSN： 1054-3406

Source： Journal of Biopharmaceutical Statistics, Vol.19, Iss.4, 2009-07, pp. : 595-609

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sample Size Re-Estimation for Adaptive Sequential Design in Clinical Trials

By Gao Ping

Journal of Biopharmaceutical Statistics, Vol. 18, Iss. 6, 2008-11 ,pp. : 1184-1196

Taylor & Francis Ltd

Access to resources Recommend Favorite

Group-Sequential Methods for Adaptive Seamless Phase II/III Clinical Trials

By Stallard Nigel

Journal of Biopharmaceutical Statistics, Vol. 21, Iss. 4, 2011-07 ,pp. : 787-801

Taylor & Francis Ltd

Access to resources Recommend Favorite

Seamless Phase II/III Combination Study Through Response Adaptive Randomization

By Wang Lin

Journal of Biopharmaceutical Statistics, Vol. 17, Iss. 6, 2007-11 ,pp. : 1177-1187

Taylor & Francis Ltd

Access to resources Recommend Favorite

Conservative Sample Size Estimation in Nonparametrics

By De Martini Daniele

Journal of Biopharmaceutical Statistics, Vol. 21, Iss. 1, 2011-01 ,pp. : 24-41

Taylor & Francis Ltd

Access to resources Recommend Favorite

The changing landscape of phase II/III metastatic NSCLC clinical trials and the importance of biomarker selection criteria

Cancer, Vol. 120, Iss. 24, 2014-12 ,pp. : 3853-3858

Blackwell Publishing

Access to resources Recommend Favorite